News
Why Is Apple Inc. Reporting Its Fourth-Quarter Results So Late?
Apple (NASDAQ: AAPL) recently announced that it plans to report its financial results for the fourth quarter of its fiscal year 2017 on Nov. 2. This, as some have pointed out, is late compared to....
Better Buy: McDonald's vs. Restaurant Brands International
In today's restaurant stock matchup, I've got Restaurant Brands International (NYSE: QSR) facing off against McDonald's (NYSE: MCD).Restaurant Brands International -- which owns the Tim Hortons,....
Disney World's Top Rival Shrinks to Grow
Comcast's (NASDAQ: CMCSA) Universal Orlando is closing down another attraction tonight. Terminator 2: 3-D, one of the oldest existing attractions at Universal Studios Florida, will end its 21-year....
Google Hits Back at Facebook and Snap on Mobile
Discovering content on the internet is no longer an active pursuit. People simply open an app and passively consume content. Whether that app is Facebook (NASDAQ: FB), Instagram, Snap's (NYSE:....
Intel Corp.'s Plan to Sell More Expensive Chips
Recently, various tech websites spotted a change that microprocessor giant Intel (NASDAQ: INTC) is making to the branding of its value-priced Pentium processor lineup.For years now, Intel has had....
3 Reasons Intel Can Win the Self-Driving Car Race
Intel (NASDAQ: INTC) has definitely come a long way since the March announcement of its acquisition of vision specialist Mobileye for a princely sum of $15.3 billion. This move is now acting as a....
Amazon Is Not a Retail Company -- at Least Not Anymore
Amazon (NASDAQ: AMZN) is practically synonymous with online retail. A growing majority of Americans start their online shopping searches at Amazon.com. It recently made a big expansion into the....
5 Dividend Stocks That Pay Out Over $2.5 Billion a Year
Looking for income? Dividend stocks are a great place to find it. And the good news is that big payouts can be found throughout the stock market, regardless of industry or sector. Whether you're....
202 Million Americans Disapprove of Republicans' Handling of Healthcare Reform, Survey Shows
There has arguably not been a more hot-button issue on Capitol Hill this year than healthcare reform, and it's not hard to understand why. Heading into the Oval Office, Donald Trump had pledged....
NVIDIA Scores 2 Drone Wins -- Including the AI for an E-Commerce Giant's Delivery Drones
NVIDIA (NASDAQ: NVDA) is on track -- or perhaps we should say on a flight path -- to conquer the small unmanned aerial vehicle, or drone, space. Within the past month, the graphics-chip specialist....
Roundtable: 1 Stock Retirees Should Consider
Time magazine declares that "70 is the new 50." And just because you're retired doesn't mean it's time to stop investing. In fact, retirement may be the best time to invest in stocks. Seriously,....
Is Starbucks Corporation a Buy?
If you've been waiting for a better price before buying Starbucks (NASDAQ: SBUX) stock, your patience has been rewarded. The coffee giant's shares have lost ground in 2017 even as the broader....
The Biggest Winners If T-Mobile and Sprint Merge
T-Mobile (NASDAQ: TMUS) and Sprint (NYSE: S) are reportedly close to agreeing on terms to merge their respective companies into one entity. The third- and fourth-place carriers have held....
News Flash: The FDA Just Approved a Breakthrough Diabetes Device
Diabetes is often referred to in the medical community as the "silent killer." Affecting more than 30 million people in the U.S. (9.4% of the population), diabetes was listed the cause of death....
3 Scorching-Hot Oil Stocks -- Are They Buys?
Crude oil has rallied without much fanfare over the past several months, recently notching gains of more than 20% off the bottom to set off a new bull market. That rebound in crude prices has....
Wal-Mart Aims for Amazon's Achilles Heel
Amazon.com (NASDAQ: AMZN) has done a lot of things exceptionally well over its 22-year history. The company's whopping market value and constant growth are testaments to its strategy of customer....
What's Behind AstraZeneca's September Rebound?
After a tough couple of months, British pharma giant AstraZeneca (NYSE: AZN) actually saw its shares rise by a healthy 12.5% last month, according to data from S&P Global Market Intelligence.....
3 High-Yield Healthcare Stocks
Picking solid high-yield dividend stocks can be tricky. Most companies that offer an elevated yield, after all, tend to do so because of a fundamental weakness in their underlying business. Our....
A Strong Case for Buying Franco-Nevada Corp Over Wheaton Precious Metals
Franco-Nevada Corp (NYSE: FNV) and Wheaton Precious Metals (NYSE: WPM) each provides investors exposure to precious metals in a unique way. But one of the main reasons to add gold and silver to....
3 Top Med-Tech Stocks You Can Buy Right Now
How much will the medical technology (med-tech) industry grow in the coming years? According to market research firm Evaluate, med-tech is on track to grow by 5.1% annually by 2022. That might not....
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin just might be the most controversial topic in the investing world. Supporters think the cryptocurrency has the potential to disrupt the financial industry. They also point to bitcoin's....
Will the SpaceX BFR Kill Airline Stocks?
Elon Musk has big plans for Mars, for the moon -- and as it just so happens, for Earth, too.As we learned at Musk's brief talk in Adelaide, Australia, last week, SpaceX is hard at work designing a....
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
"Dividend Aristocrat" just has a nice ring to it, doesn't it? The "dividend" part sounds great because it means a stock is going to pay you to own it. "Aristocrat" conveys nobility, an elite....
Best Buy: CVS Health, Walgreens, or Rite Aid?
Three pharmacy retailers combined make more than 40% of all revenue from prescriptions in the U.S. CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) are the nation's largest....
AbbVie's Fast Becoming a Top Stock to Buy Now
AbbVie Inc.'s (NYSE: ABBV) making considerable progress toward reducing its reliance on its top-selling autoimmune disease drug, Humira, and recent patent news that could sideline Humira....